KK
Kollipara Koteswara Rao
About Kollipara Koteswara Rao
Data last updated:
Kollipara Koteswara Rao is a Managing Director at Transgene Biotek Limited (since 2020), Director at Niedlfree Technologies Private Limited (since 2021) and Director at Neodel Pharma Private Limited (since 2021). The companies operate in Life Sciences, Healthcare and Biotechnology. The 2 current companies with reported revenue have a combined latest revenue of ₹1.23 Cr; the largest is Transgene Biotek Limited at ₹1.04 Cr (FY 2025). Earlier, Kollipara Koteswara Rao was a Director at Strategene Biotech Private Limited (2013–2015) and Director at Peroral Bio Private Limited (from 2020) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 04 Mar 2020 | 1990 | ₹1.04 Cr (FY 2025) | Active | |
| Director | 21 Sep 2021 | 2021 | ₹18.8 Lakh (FY 2025) | Active | |
| Director | 17 Mar 2021 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Feb 2013 | 2013 | Strike Off | ||
| Director | 23 Dec 2020 | 2020 | Strike Off | ||
| Director | 31 Jul 2008 | 2008 | Strike Off | ||
| Director | 31 Jul 2008 | 2008 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Kollipara Koteswara Rao
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ankita Jain | Transgene Biotek Limited | Company Secretary | |
| Chowdari Prasad | Transgene Biotek Limited | Cfo | |
| Santhosh Kumar | 08658555 | Transgene Biotek Limited | Director |
| Sujana Kadiam | 07167872 | Transgene Biotek Limited | Director |
| Swetha Marri | 08754103 | Transgene Biotek Limited | Director |
| Jeetendra Ambulge Kashinath | 07822881 | Niedlfree Technologies Private Limited | Director |
| Prakash Babu Nanduri | 07570954 | Niedlfree Technologies Private Limited | Additional Director |
| Viswanath Toshniwal | 06862637 | Niedlfree Technologies Private Limited , Neodel Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kollipara Koteswara Rao
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kollipara Koteswara Rao
Kollipara Koteswara Rao currently holds 3 directorships: Transgene Biotek Limited (Managing Director, since 04 Mar 2020, revenue ₹1.04 Cr (FY 2025)); Niedlfree Technologies Private Limited (Director, since 21 Sep 2021, revenue ₹18.8 Lakh (FY 2025)); Neodel Pharma Private Limited (Director, since 17 Mar 2021).
Kollipara Koteswara Rao was first appointed on 31 Jul 2008 as Director at Diamond Life Properties Limited. The most recent appointment on record is 21 Sep 2021 at Niedlfree Technologies Private Limited.
The 2 current companies of Kollipara Koteswara Rao that report revenue have a combined latest revenue of ₹1.23 Cr: Transgene Biotek Limited ₹1.04 Cr (FY 2025); Niedlfree Technologies Private Limited ₹18.8 Lakh (FY 2025).
Kollipara Koteswara Rao held 4 earlier board appointments: Strategene Biotech Private Limited (Director, 15 Feb 2013 to 04 Dec 2015); Peroral Bio Private Limited (Director, from 23 Dec 2020); Diamond Life Properties Limited (Director, from 31 Jul 2008); Diamond Life Pan India Properties Limited (Director, from 31 Jul 2008).
The current boards of Kollipara Koteswara Rao's companies include Ankita Jain (Transgene Biotek Limited), Chowdari Prasad (Transgene Biotek Limited), Santhosh Kumar (Transgene Biotek Limited), Sujana Kadiam (Transgene Biotek Limited), Swetha Marri (Transgene Biotek Limited), Jeetendra Ambulge Kashinath (Niedlfree Technologies Private Limited), among others.